Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER

Endometrial Carcinoma

Novartis Pharmaceuticalsmonoclonal_antibodyPhase 1/2Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

234 Active assets in the Endometrial Carcinoma cohort.

Asset / SponsorPhaseRating
Indocyanine Green
Istanbul University
Phase 4BB
Inno-206
AstraZeneca
Phase 3BB
Olaparib
Qilu Pharmaceutical Co., Ltd.
Phase 4BB
Palbociclib
University Medical Center Groningen
Phase 4BB
FILGRASTIM
Mayo Clinic
Phase 3B

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN MACROPHAGE COLONY-STIMULATING FACTOR) (HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CLONE NVS220906 .KAPPA.-CHAIN, DIMER is also rated in:

triple-negative breast carcinomaDormant
B
Indicative ·
58 / 100
View asset →
metastatic carcinoma in the boneDormant
CC
Indicative ·
42 / 100
View asset →
exocrine pancreatic carcinomaDormant
CC
Indicative ·
42 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →